β-Arrestin 2-mediated immune suppression induced by chronic stress

NeuroImmunoModulation

Volumn 18, Issue 3, 2011, Pages 142-149

  Li, Hui ^a   Smalligan, Dean Andrew ^a   Xie, Nanchang ^a   Javer, Avani ^a   Zhang, Yi ^a   Hanley, Gregory ^a   Yin, Deling ^a  

^a East Tennessee State University   (United States)

Author keywords

Arrestin 2; Immunosuppression; PI3K; Restraint stress; Splenocyte reduction

Indexed keywords

BETA ARRESTIN 2; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CHRONIC STRESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DOWN REGULATION; IMMOBILIZATION STRESS; IMMUNE DYSREGULATION; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN CELL; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; ARRESTINS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; STRESS, PSYCHOLOGICAL;

EID: 78651254392     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322868     Document Type: Article

References (44)

1. Frieri M: Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann Allergy Asthma Immunol 2003; 90: 34-40. (Pubitemid 36712688)
2. Yang EV, Glaser R: Stress-associated immunomodulation and its implications for responses to vaccination. Expert Rev Vaccines 2002; 1: 453-459. (Pubitemid 36559952)
3. Sonnenfeld G: Immune responses in space flight. Int J Sports Med 1998; 19(suppl 3):S195-S202.
4. Dhabhar FS, McEwen BS: Acute stress enhances while chronic stress suppresses cellmediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 1997; 11: 286-306. (Pubitemid 28108139)
5. Shi Y, Devadas S, Greeneltch KM, Yin D, Allan MR, Zhou JN: Stressed to death: implication of lymphocyte apoptosis for psychoneuroimmunology. Brain Behav Immun 2003; 17(suppl 1):S18-S26. (Pubitemid 36298509)
6. Reiche EM, Nunes SO, Morimoto HK: Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5: 617-625. (Pubitemid 39303129)
7. Quan N, Avitsur R, Stark JL, He L, Shah M, Caligiuri M, Padgett DA, Marucha PT, Sheridan JF: Social stress increases the susceptibility to endotoxic shock. J Neuroimmunol 2001; 115: 36-45. (Pubitemid 32245651)
8. Zhang Y, Zhang Y, Miao J, Hanley G, Stuart C, Sun X, Chen T, Yin D: Chronic restraint stress promotes immune suppression through Toll-like receptor 4-mediated phosphoinositide 3-kinase signaling. J Neuroimmunol 2008; 204: 13-19.
9. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K: The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001; 15: 199-226. (Pubitemid 33070955)
10. Yin D, Tuthill D, Mufson RA, Shi Y: Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J Exp Med 2000; 191: 1423-1428. (Pubitemid 30227128)
11. Yin D, Zhang Y, Stuart C, Miao J, Zhang Y, Li C, Zeng X, Hanley G, Moorman J, Yao Z, Woodruff M: Chronic restraint stress modulates expression of genes in murine spleen. J Neuroimmunol 2006; 177: 11-17. (Pubitemid 44108234)
12. Zhang Y, Foster R, Sun X, Yin Q, Li Y, Hanley G, Stuart C, Gan Y, Li C, Zhang Z, Yin D: Restraint stress induces lymphocyte reduction through p53 and PI3K/NF- B pathways. J Neuroimmunol 2008; 200: 71-76.
13. Cao L, Hudson CA, Moynihan JA: Chronic foot shock induces hyperactive behaviors and accompanying pro- and anti-inflammatory responses in mice. J Neuroimmunol 2007; 186: 63-74. (Pubitemid 46783837)
14. Zhang Y, Woodruff M, Zhang Y, Miao J, Hanley G, Stuart C, Zeng X, Prabhakar S, Moorman J, Zhao B, Yin D: Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression. J Neuroimmunol 2008; 194: 115-122.
15. Lefkowitz RJ, Shenoy SK: Transduction of receptor signals by beta-arrestins. Science 2005; 308: 512-517.
16. Moore CA, Milano SK, Benovic JL: Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 2007; 69: 451-482. (Pubitemid 46457651)
17. Buchanan FG, DuBois RN: Emerging roles of beta-arrestins. Cell Cycle 2006; 5: 2060-2063.
18. Nelson CD, Perry SJ, Regier DS, Prescott SM, Topham MK, Lefkowitz RJ: Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. Science 2007; 315: 663-666. (Pubitemid 46214713)
19. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD: Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci USA 2002; 99: 7478-7483. (Pubitemid 34568716)
20. Revankar CM, Vines CM, Cimino DF, Prossnitz ER: Arrestins block G proteincoupled receptor-mediated apoptosis. J Biol Chem 2004; 279: 24578-24584. (Pubitemid 38725324)
21. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G: Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2006; 7: 139-147. (Pubitemid 43135879)
22. Franke TF, Kaplan DR, Cantley LC: PI3K: downstream AKTion blocks apoptosis. Cell 1997; 88: 435-437. (Pubitemid 27154408)
23. Cantley LC: The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657. (Pubitemid 34579158)
24. Okkenhaug K, Vanhaesebroeck B: PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 2003; 3: 317-330. (Pubitemid 37328684)
25. Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfleisch JH, Preiszner J, Brooks L, Breuel K, Schweitzer JB: Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol 2004; 172: 449-456. (Pubitemid 38020500)
26. Arruda MA, Rossi AG, de Freitas MS, Barja- Fidalgo C, Graca-Souza AV: Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF- B. J Immunol 2004; 173: 2023-2030. (Pubitemid 38971639)
27. Povsic TJ, Kohout TA, Lefkowitz RJ: Betaarrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J Biol Chem 2003; 278: 51334-51339. (Pubitemid 38020372)
28. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG: An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005; 122: 261-273. (Pubitemid 41032989)
29. Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ: Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell 2009; 17: 443-458.
30. Sheridan JF, Dobbs C, Jung J, Chu X, Konstantinos A, Padgett D, Glaser R: Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann NY Acad Sci 1998; 840: 803-808. (Pubitemid 28302105)
31. Yin D, Zhang L, Wang R, Radvanyi L, Haudenschild C, Fang Q, Kehry MR, Shi Y: Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. J Immunol 1999; 163: 4328-4334. (Pubitemid 29474499)
32. Yin D, Woodruff M, Zhang Y, Whaley S, Miao J, Ferslew K, Zhao J, Stuart C: Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF- B pathways. J Neuroimmunol 2006; 174: 101-107.
33. Dhabhar FS, McEwen BS: Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci USA 1999; 96: 1059-1064. (Pubitemid 29072183)
34. Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD: MHC class II+ exosomes in plasma suppress inflammation in an antigen- specific and Fas ligand/Fas-dependent manner. J Immunol 2007; 179: 2235-2241.
35. Moorman J, Zhang Y, Liu B, LeSage G, Chen Y, Stuart C, Prayther D, Yin D: HIV-1 gp120 primes lymphocytes for opioid-induced, beta- arrestin 2-dependent apoptosis. Biochim Biophys Acta 2009; 1793: 1366-1371.
36. Zhao M, Zhou G, Zhang Y, Chen T, Sun X, Stuart C, Hanley G, Li J, Zhang J, Yin D: Beta- arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways. Neoplasma 2009; 56: 108-113.
37. Li Y, Sun X, Zhang Y, Huang J, Hanley G, Ferslew KE, Peng Y, Yin D: Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2. Biochem Biophys Res Commun 2009; 378: 857-861.
38. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG: Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 2000; 408: 720-723. (Pubitemid 32015987)
39. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT: Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 1999; 286: 2495-2498.
40. Adi S, Wu NY, Rosenthal SM: Growth factor- stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and wortmannin. Endocrinology 2001; 142: 498-501. (Pubitemid 32183714)
41. Hawkley LC, Cacioppo JT: Stress and the aging immune system. Brain Behav Immun 2004; 18: 114-119. (Pubitemid 38169155)
42. Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB: CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 2006; 176: 2085-2094. (Pubitemid 43201655)
43. Kono K, Takahashi A, Iizuka H, Fujii H, Sekikawa T, Matsumoto Y: Effect of oesophagectomy on monocyte-induced apoptosis of peripheral blood T lymphocytes. Br J Surg 2001; 88: 1110-1116. (Pubitemid 32868667)
44. Osaki M, Kase S, Adachi K, Takeda A, Hashimoto K, Ito H: Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. J Cancer Res Clin Oncol 2004; 130: 8-14. (Pubitemid 38161242)